PMV Pharmaceuticals Inc. (PMVP)
undefined
undefined%
At close: undefined
1.58
-0.32%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue - - - - - -
Cost of Revenue 1.26M 650.00K 1.28M 318.00K 388.00K 338.00K
Gross Profit -1.26M -650.00K -1.28M -318.00K -388.00K -338.00K
Operating Income -80.13M -77.04M -58.29M -34.94M -26.64M -18.89M
Interest Income 11.17M 3.63M 449.00K 651.00K 1.30M 1.34M
Pretax Income -68.96M -73.33M -57.82M -34.43M -25.34M -17.54M
Net Income -68.96M -73.32M -57.85M -34.44M -25.35M -17.54M
Selling & General & Admin 24.25M 25.05M 21.80M 11.01M 5.88M 5.04M
Research & Development 55.88M 51.99M 36.49M 23.93M 20.76M 13.85M
Other Expenses - 87.00K 21.00K -143.00K -8.00K 16.00K
Operating Expenses 80.13M 77.04M 58.29M 34.94M 26.64M 18.89M
Interest Expense - - - - - -
Selling & Marketing Expenses - - - - - -
Cost & Expenses 80.13M 77.04M 58.29M 34.94M 26.64M 18.89M
Income Tax 2.00K -9.00K 23.00K 6.00K 8.00K 3.00K
Shares Outstanding (Basic) 48.01M 45.59M 45.14M 44.78M 43.00M 31.23M
Shares Outstanding (Diluted) 48.01M 45.59M 45.14M 44.78M 43.00M 31.23M
EPS (Basic) -1.44 -1.61 -1.28 -0.77 -0.59 -0.56
EPS (Diluted) -1.44 -1.61 -1.28 -0.77 -0.59 -0.56
EBITDA -78.88M -76.72M -57.99M -34.62M -26.25M -18.55M
Depreciation & Amortization 1.26M 650.00K 1.28M 318.00K 388.00K 338.00K